Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.17 (
lysozyme
)
21,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Myeloid elf-1-like factor (MEF) or Elf4, which is a member of the ETS transcription factor family, up-regulates the basal expression of
lysozyme
gene in epithelial cells and is constitutively localized in the nucleus. The mammalian cell nucleus is organized into distinct nuclear domains or compartments that are essential for diverse physiological processes.
Promyelocytic leukemia
(
PML
) nuclear body or nuclear domain 10 is one of the nuclear domains and is involved in tumor suppression and regulation of transcription. Here, we investigate the role of
PML
nuclear body in MEF transactivation. We show that
PML
, but not Sp100, induced the accumulation of MEF in
PML
nuclear bodies and that MEF and
PML
physically interacted. This interaction stimulated MEF transcriptional activity, resulting in the up-regulation of endogenous
lysozyme
expression. Amino acids 348-517 of MEF were required for the accumulation of MEF in
PML
nuclear bodies and up-regulation of
lysozyme
transcription, which is enhanced by
PML
. Moreover, the C-terminal region of MEF spanning amino acids 477-517 was the putative region required for interaction between MEF and
PML
as determined with the use of the mammalian two-hybrid system. In addition, heat-shock treatment induced the accumulation of MEF in endogenous
PML
nuclear bodies and enhanced MEF transactivation of
lysozyme
gene. Thus, the recruitment of MEF to
PML
nuclear bodies may partly regulate
lysozyme
transcription in epithelial cells.
...
PMID:Myeloid Elf-1-like factor, an ETS transcription factor, up-regulates lysozyme transcription in epithelial cells through interaction with promyelocytic leukemia protein. 1497 84